Combination therapy with pazopanib and tivantinib modulates VEGF and c-MET levels in refractory advanced solid tumors
Shivaani Kummar(Oregon Health & Science University), Alice P. Chen(National Cancer Institute)
Cited by 7
Related Papers
Phase 1 studies of the indenoisoquinolines LMP776 and LMP744 in patients with solid tumors and lymphomas
|Cancer Chemotherapy and Pharmacology|2025|3